ACHIEVEMENT OF LOW DISEASE ACTIVITY OR REMISSION WITH ETANERCEPT-METHOTREXATE THERAPY IN SUBJECTS WITH MODERATELY ACTIVE RHEUMATOID ARTHRITIS: PRELIMINARY RESULTS FROM THE PRESERVE TRIAL

被引：0
|
作者：
Smolen, Josef S. [1 ,2 ]
Freundlich, Bruce [3 ]
Pavelka, Karel [4 ,5 ]
Nash, Peter [6 ]
Miranda, Pedro [7 ,8 ]
Hammond, Constance [9 ]
Vlahos, Bonnie [9 ]
Pedersen, Ronald [9 ]
Koenig, Andrew S. [9 ]
机构：
[1] Med Univ Vienna, Div Rheumatol, Vienna, Austria
[2] Hietzing Hosp, Vienna, Austria
[3] Univ Penn, Dept Rheumatol, Philadelphia, PA 19104 USA
[4] Charles Univ Prague, Inst Rheumatol, Prague, Czech Republic
[5] Charles Univ Prague, Clin Rheumatol, Prague, Czech Republic
[6] Univ Queensland, Dept Med, Brisbane, Qld 4000, Australia
[7] Univ Chile, Dept Rheumatol, Santiago, Chile
[8] Hosp San Juan Dios, Santiago, Chile
[9] Pfizer Inc, Dept Specialty Care, Collegeville, PA USA
来源：
RHEUMATOLOGY | 2011年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：ii12 / ii12
页数：1
相关论文
共 50 条
  • [41] Utility of Vectra-DA™ On Assessment of Rheumatoid Arthritis Disease Activity and Golimumab Response: Results of a Pilot Study From a Phase 3 Trial in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy.
    Lamberth, Sarah
    Cherkas, Yauheniya
    Brodmerkel, Carrie
    Curran, Mark
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S916 - S916
  • [42] Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial
    Kekow, J.
    Moots, R. J.
    Emery, P.
    Durez, P.
    Koenig, A.
    Singh, A.
    Pedersen, R.
    Robertson, D.
    Freundlich, B.
    Sato, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) : 222 - 225
  • [43] CHANGES IN SERUM LEVELS OF CYTOKINES WITH METHOTREXATE MONOTHERAPY IN ACTIVE RHEUMATOID ARTHRITIS: RESULTS FROM A MULTICENTRE, RANDOMIZED CONTROLLED TRIAL ON METHOTREXATE ESCALATION IN RHEUMATOID ARTHRITIS
    Jain, Siddharth
    Dhir, Varun
    Aggarwal, Amita
    Gupta, Ranjan
    Maurya, Supriya
    Leishangthem, Bidyalaxmi
    Khullar, Aastha
    Naidu, Shankar
    Sharma, Shefali K.
    Sharma, Aman
    Jain, Sanjay
    RHEUMATOLOGY, 2023, 62
  • [44] Clinical remission, radiographic non-progression, and normalized function with the combination of etanercept and methotrexate in the treatment of early active rheumatoid arthritis: 1-year results of the COMET trial
    Emery, P.
    Breedveld, F. C.
    Hall, S.
    Durez, P.
    Chang, D. J.
    Pedersen, R.
    Koenig, A. S.
    Robertson, D.
    Freundlich, B.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S617 - S617
  • [45] In Rheumatoid Arthritis Patients With Stable Low Disease Activity On Methotrexate Plus Etanercept, Continuation Of Etanercept Is Superior Both Clinically and Radiographically To Discontinuation: Results From a Randomized, 3-Armed, Double-Blind Clinical Trial
    Oster-Gaard, Mikkel
    Leirisalo-Repo, Marjatta
    Uhlig, Till
    Jansson, Marita
    Larsson, Esbjoen
    Brock, Fiona
    van Vollenhoven, Ronald F.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1017 - S1018
  • [46] PROBABILITY OF ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH APREMILAST
    Mease, Philip J.
    Behrens, Frank
    Gladman, Dafna D.
    Kavanaugh, Arthur
    Brunori, Michele
    Teng, Lichen
    Guerette, Benoit
    Queiro, Ruben
    Ogdie, Alexis
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 916 - 917
  • [47] Changes in Lipoproteins Associated With Methotrexate or Combination Therapy in Early Rheumatoid Arthritis: Results From the Treatment of Early Rheumatoid Arthritis Trial
    Navarro-Millan, Iris
    Charles-Schoeman, Christina
    Yang, Shuo
    Bathon, Joan M.
    Bridges, S. Louis, Jr.
    Chen, Lang
    Cofield, Stacey S.
    Dell'Italia, Louis J.
    Moreland, Larry W.
    O'Dell, James R.
    Paulus, Harold E.
    Curtis, Jeffrey R.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (06): : 1430 - 1438
  • [48] Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial (vol 383, pg 321, 2014)
    Smolen, J. S.
    Emery, P.
    Fleischmann, R.
    LANCET, 2014, 383 (9914): : 308 - 308
  • [49] Maintenance of low disease activity and remission with etanercept-disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis Subset analysis of a randomized trial
    Zerbini, Cristiano A. F.
    Abud-Mendoza, Carlos
    Mendez-Patarroyo, Paul
    Andrade, Mauricio De Angelo
    Pedersen, Ron
    Vlahos, Bonnie
    Borlenghi, Cecilia Elena
    MEDICINE, 2018, 97 (36)
  • [50] Exposure-Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis
    Paul, Stephane
    Marotte, Hubert
    Kavanaugh, Arthur
    Goupille, Philippe
    Kvien, Tore K.
    de Longueville, Marc
    Mulleman, Denis
    Sandborn, William J.
    Vande Casteele, Niels
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (04): : 743 - 751
12345